Resum
Ocular toxicities related to systemic antineoplastic treatments are underestimated. This is a case report of a bilateral cataract of acute onset secondary to rociletinib. The clinical course of the cataract was more rapid than a typical senile cataract, with a severe impact in the patient’s quality of life. Surgical approach with a bilateral cataract surgery was needed to restore both the eye and the general patient functioning. The case is a reminder of the potential toxicities related to new antineoplastic drugs and the need for an interdisciplinary approach to recognize and treat these ocular toxicities.
| Idioma original | Anglès |
|---|---|
| Número d’article | 3 |
| Nombre de pàgines | 5 |
| Revista | Precision Cancer Medicine |
| Volum | 1 |
| Número | Issue June |
| DOIs | |
| Estat de la publicació | Publicada - de juny 2018 |
Paraules clau
- Cataract
- Epidermal growth factor receptor (EGFR)
- Rociletinib
SDG de les Nacions Unides
Aquest resultat contribueix als següents objectius de desenvolupament sostenible.
